Angiogenesis in gastric mucosa: An important component of gastric erosion and ulcer healing and its impairment in aging

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue S4, 2014, Pages 112-123

  Tarnawski, Andrzej S ^a,b   Ahluwalia, Amrita ^a,b   Jones, Michael K ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging gastric mucosa; Angiogenesis; Growth factors; Healing; Injury; Serum response factor

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; CALCITONIN GENE RELATED PEPTIDE; CORTICOSTEROID; CYCLOOXYGENASE 2; EARLY GROWTH RESPONSE FACTOR 1; GHRELIN; KARYOPHERIN; MELATONIN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROSTAGLANDIN; SERUM RESPONSE FACTOR; SURVIVIN; VASCULOTROPIN; EGR1 PROTEIN, HUMAN; PTEN PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN; VASCULOTROPIN A;

AGING; ANGIOGENESIS; ARTICLE; ENDOTHELIAL PROGENITOR CELL; HUMAN; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH EROSION; STOMACH MUCOSA; STOMACH MUCOSA BLOOD FLOW; ULCER HEALING; BONE MARROW CELL; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; STOMACH ULCER; VASCULARIZATION;

AGING; BONE MARROW CELLS; CYCLOOXYGENASE 2; EARLY GROWTH RESPONSE PROTEIN 1; ENDOTHELIAL PROGENITOR CELLS; GASTRIC MUCOSA; HUMANS; KARYOPHERINS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; PROSTAGLANDINS; PTEN PHOSPHOHYDROLASE; REGENERATION; SERUM RESPONSE FACTOR; STOMACH ULCER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84919449427     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12734     Document Type: Article

References (64)

1. Cotran RS, Kumar V, Robbins SL. Gastric ulceration. In: Cotran RS, Kumar V, Robbins SL, eds. Robins Pathologic Basis of Disease, 5th edn. Philadelphia, MA: Saunders, 1994; 773-777.
2. Tarnawski A, Hollander D, Stachura J, Gergely H, Krause WJ, Sarfeh IJ. Role of angiogenesis in healing of experimental gastric ulcer. In: Halter F, Gamer A, Tytgat GNJ, eds. Mechanisms of Peptic Ulcer Healing. Dordrecht; Boston, MA; London: Kluwer Acad. Publ, 1991; 165-171.
3. Tarnawski AS. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig. Dis. Sci. 2005; 50 (Suppl. 1): S24-S33.
4. Tarnawski A, Hollander D, Krause WJ, Dabros W, Stachura J, Gergely H. "Healed" experimental gastric ulcers remain histologically and ultrastructurally abnormal. J. Clin. Gastroenterol. 1990; 12 (Suppl. 1): 139-147.
5. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-673.
6. Folkman J, D'Amore PA. Blood vessel formation: its molecular basis? Cell 1996; 87: 1153-1155.
7. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005; 438: 967-974.
8. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 2003; 9: 653-660.
9. Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y. Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann. Surg. 1991; 214: 414-427.
10. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin HG. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Invest. 1998; 78: 1385-1394.
11. Madri JA, Williams SK. Capillary endothelial cell cultures: phenotypic modulation by matrix components. J. Cell Biol. 1983; 97: 153-165.
12. Jones MK, Wang H, Peskar BM etal. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat. Med. 1999; 5: 1418-1423.
13. Kamei M, Saunders WB, Bayless KJ, Dye L, Davis GE, Weinstein BM. Endothelial tubes assemble from intracellular vacuoles in vivo. Nature 2006; 442: 453-456.
14. Ferrara N. The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS 2005; 94: 209-231.
15. Ferrara N. VEGF basic science and clinical progress. Endocr. Rev. 2004; 25: 581-611.
16. Jones MK, Itani RM, Wang H etal. Activation of VEGF and RAS genes in gastric mucosa during angiogenic response to ethanol injury. Am. J. Physiol. 1999; 276: G1345-1355.
17. Cao Y. Endogenous angiogenesis inhibitors and their therapeutic implications. Int. J. Biochem. Cell Biol. 2001; 33: 357-369.
18. Dhanabal M, Volk R, Ramchandran R, Simons M, Sukhatme VP. Cloning, expression, and in vitro activity of human endostatin. Biochem. Biophys. Res. Commun. 1999; 258: 345-352.
19. Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaisse J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 2000; 486: 247-251.
20. Chung AS, Lee J, Ferrara N. Targeting the tumour vasculature: insights from physiological angiogenesis. Nat. Rev. Cancer 2010; 10: 505-514.
21. Jain RK. Molecular regulation of vessel maturation. Nat. Med. 2003; 9: 685-693.
22. Sen S, McDonald SP, Coates PT, Bonder CS. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin. Sci. (Lond) 2011; 120: 263-283.
23. Asahara T, Murohara T, Sullivan A etal. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
24. Shi Q, Rafii S, Wu MH, Wijelath ES etal. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-367.
25. Crosby JR, Kaminski WE, Schatteman G etal. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ. Res. 2000; 87: 728-730.
26. Zhang ZG, Zhang L, Jiang Q, Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ. Res. 2002; 90: 284-288.
27. Hess DC, Hill WD, Martin-Studdard A, Carroll J, Brailer J, Carothers J. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 2002; 33: 1362-1368.
28. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003; 108: 2511-2516.
29. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 2004; 95: 343-353.
30. Lau TT, Wang DA. Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Expert Opin. Biol. Ther. 2011; 11: 189-197.
31. Duarte RF, Frank DA. The synergy between stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF): molecular basis and clinical relevance. Leuk. Lymphoma 2002; 43: 1179-1187.
32. Hatazawa R, Tanaka A, Tanigami M etal. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 293: G788-797.
33. Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y. Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann. Surg. 1991; 214: 414-425. discussion 426-27.
34. Szabo S, Folkman J, Vattay P, Morales RE, Pinkus GS, Kato K. Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats. Gastroenterology 1994; 106: 1106-1111.
35. Jones MK, Kawanaka H, Baatar D etal. Gene therapy for gastric ulcers. With single local injection of VEGF naked DNA encoding VEGF and angiopoietin-1. Gastroenterology 2001; 121: 1040-1047.
36. Hudson N, Balsitis M, Everitt S, Hawkey CJ. Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs. Gut 1995; 37: 191-194.
37. Jones MK, Szabó IL, Kawanaka H, Husain SS, Tarnawski AS. von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis. FASEB J. 2002; 16: 264-266.
38. Tarnawski A, Hollander D, Stachura J, Krause WJ, Gergely H. Prostaglandin protection of the gastric mucosa against alcohol injury-a dynamic time-related process. Role of the mucosal proliferative zone. Gastroenterology 1985; 88 (1 Pt 2): 334-352.
39. Tarnawski A, Hollander D, Stachura J. Ultrastructural changes in the gastric mucosal microvessels after ethanol. Gastroenterol. Clin. Biol. 1985; 9 (12 Pt 2): 93-97.
40. Ahluwalia A, Jones MK, Deng X, Sandor Z, Szabo S, Tarnawski AS. An imbalance between VEGF and endostatin underlies impaired angiogenesis in gastric mucosa of aging rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2013; 305: G325-332.
41. Florkiewicz RZC, Ahluwalia A, Sandor Z, Szabo S, Tarnawski AS. Gastric mucosal injury activates bFGF gene expression and triggers preferential translation of high molecular weight bFGF isoforms through CUG-initiated, non-canonical codons. Biochem. Biophys. Res. Commun. 2011; 409: 494-499.
42. Chai J, Baatar D, Tarnawski AS. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis: insight into the mechanisms. FASEB J. 2004; 18: 1264-1266.
43. Lange A, Mills RE, Lange CJ, Stewart M, Devine SE, Corbett AH. Classical nuclear localization signals: definition, function, and interaction with importin alpha. J. Biol. Chem. 2007; 282: 5101-5105.
44. Depping R, Steinhoff A, Schindler SG etal. Nuclear translocation of hypoxia-inducible factors (HIFs): involvement of the classical importin alpha/beta pathway. Biochim. Biophys. Acta 2008; 1783: 394-404.
45. Ahluwalia A, Jones MK, Tarnawski AS. Key role of endothelial importin α in VEGF expression and gastric angiogenesis: novel insight into aging gastropathy. Am. J. Physiol. Gastrointest. Liver Physiol. 2014; 306: G338-345.
46. Sato T, Amano H, Ito Y etal. Vascular endothelial growth factor receptor 1 signaling facilitates gastric ulcer healing and angiogenesis through the upregulation of epidermal growth factor expression on VEGFR1(+)CXCR4 (+) cells recruited from bone marrow. J. Gastroenterol. 2014; 49: 455-469.
47. Sato T, Amano H, Ito Y etal. D, aspirin delays gastric ulcer healing with reduced accumulation of CXCR4(+)VEGFR1(+) cells to the ulcer granulation tissues. Biomed. Pharmacother. 2013; 67: 607-613.
48. Tarnawski AS, Ahluwalia A, Jones MK, Sandor Z, Szabo S. New insight into gastric ulcer healing: direct evidence that bone marrow derived endothelial progenitor cells form in granulation tissue new hybrid blood vessels jointly with local endothelial cells. Gastroenterology 2012; 5: S142-146.
49. Takeuchi K, Kato S, Amagase K. Prostaglandin EP receptors involved in modulating gastrointestinal mucosal integrity. J. Pharmacol. Sci. 2010; 114: 248-261.
50. Hatazawa R, Tanigami M, Izumi N, Kamei K, Tanaka A, Takeuchi K. Prostaglandin E2 stimulates VEGF expression in primary rat gastric fibroblasts through EP4 receptors. Inflammopharmacology 2007; 15: 214-217.
51. Pai R, Szabo IL, Soreghan BA, Atay S, Kawanaka H, Tarnawski AS. PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways. Biochem. Biophys. Res. Commun. 2001; 286: 923-928.
52. Ganguly K, Sharma AV, Reiter RJ, Swarnakar S. Melatonin promotes angiogenesis during protection and healing of indomethacin-induced gastric ulcer: role of matrix metaloproteinase-2. J. Pineal Res. 2010; 49: 130-140.
53. Dudar GK, D'Andrea LD, Di Stasi R, Pedone C, Wallace JL. A vascular endothelial growth factor mimetic accelerates gastric ulcer healing in an iNOS-dependent manner. Am. J. Physiol. Gastrointest. Liver Physiol. 2008; 295: G374-381.
54. Jones MK, Tsugawa K, Tarnawski AS, Baatar D. Dual actions of nitric oxide on angiogenesis: possible roles of PKC, ERK, and AP-1. Biochem. Biophys. Res. Commun. 2004; 318: 520-528.
55. Ohno T, Hattori Y, Komine R etal. Roles of calcitonin gene-related peptide in maintenance of gastric mucosal integrity and in enhancement of ulcer healing and angiogenesis. Gastroenterology 2008; 134: 215-225.
56. Hase S, Nakazawa S, Tsukamoto Y, Segawa K. Effects of prednisolone and human epidermal growth factor on angiogenesis in granulation tissue of gastric ulcer induced by acetic acid. Digestion 1989; 42: 135-142.
57. Li A, Cheng G, Zhu GH, Tarnawski AS. Ghrelin stimulates angiogenesis in human microvascular endothelial cells: implications beyond GH release. Biochem. Biophys. Res. Commun. 2007; 353: 238-243.
58. Szabo IL, Kawanaka H, Jones MK etal. Activation of hypoxia inducible factor-1alpha in gastric mucosa in response to ethanol injury: a trigger for angiogenesis? Life Sci. 2001; 69: 3035-3044.
59. Ichikawa Y, Tarnawski A, Sarfeh IJ, Ishikawa T, Shimada H. Distorted microangioarchitecture and impaired angiogenesis in gastric mucosa of portal hypertensive rats. Gastroenterology 1994; 106: 702-708.
60. Kawanaka H, Tomikawa M, Jones MK etal. Portal hypertensive gastric mucosa has reduced activation of MAP kinase (ERK2) in response to alcohol injury: a key to impaired healing? FASEB J. 2001; 15: 574-576.
61. Tsugawa K, Jones MK, Akahoshi T etal. Abnormal PTEN expression in portal hypertensive gastric mucosa: a key to impaired PI 3-kinase/Akt activation and delayed injury healing? FASEB J. 2003; 17: 2316-2318.
62. Kawanaka H, Jones MK, Szabo IL etal. Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-α via the PI 3-kinase-Akt signaling pathway. Hepatology 2002; 35: 393-402.
63. Grønbech JE, Lacy ER. Role of gastric blood flow in impaired defense and repair of aged rat stomachs. Am. J. Physiol. 1995; 269 (5 Pt 1): G737-744.
64. Kang JM, Kim N, Kim JH etal. Effect of aging on gastric mucosal defense mechanisms: ROS, apoptosis, angiogenesis, and sensory neurons. Am. J. Physiol. Gastrointest. Liver Physiol. 2010; 299: G1147-1153.